The stock initially rose in extended trading after Twitter easily ... Pete Najarian Long AMAT, AAPL, BAC, BMY, BP, CSX, DISCA, DKS, FOXA, GE, KKR, KO, LLY, MRK, PEP, PFE, he is long calls AAPL, AGNC, AMKR …
CNBC · 1 hour ago
Shares of Merck & Co. (NYSE:MRK) opened at 57.41 on Monday. Merck & Co. has a 1-year low of $52.49 and a 1-year high of $63.62. The stock’s 50-day moving average is $58.17 and its 200-day moving average is $58.95. The company has a market … · 1 day ago
Keytruda from Merck (NYSE:MRK) is another PD-1 inhibitor approved for MM last year ... Mylan had initially offered to acquire Perrigo for $205 in a combination of cash and its stock. Mylan subsequently raised its offer to $232.23 per Perrigo share.
Seeking Alpha · 9 hours ago
Mylan Takeover
Merck & Co. Inc. (NYSE: MRK) reported its second-quarter financial results Tuesday ... the initial response in the premarket was positive and shares were up 0.5% at $57.25. The stock has a consensus analyst price target of $65.47 and a 52-week …
Market Watch · 10 hours ago
Stocks recently featured in the blog include the Gilead Sciences Inc. (GILD), AbbVie Inc. (ABBV), Merck & Co., Inc. (MRK), Achillion Pharmaceuticals, Inc. (ACHN) and Express Scripts ( ESRX). Today, Zacks is promoting its ''Buy'' stock recommendations.
Yahoo News · 8 hours ago
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box o. Note ...
StreetInsider · 9 hours ago
Merck MRK 0.93 % & Co. in May submitted a new drug application for ... Excluding expenses related to stock-based compensation, acquisitions and restructuring, as well as other items, per-share earnings rose to $3.
Wall Street Journal · 4 hours ago
Hepatitis Drugs
Wall Street stock futures are opening higher this morning ... Other pharmaceutical companies reporting today include Pfizer PFE and Merck & Co. MRK. Both are likely to see their bottom lines hit by the stronger dollar.
FORTUNE · 13 hours ago
Zacks now has a $11.00 price target on that stock. Shares of Merck & Co. (NYSE:MRK) traded up 1.03% during mid-day trading on Thursday, hitting $58.82. The stock had a trading volume of 5,324,634 shares. Merck & Co. has a 52 week low of $52.49 … · 7/16/2015
Trefis currently covers Johnson & Johnson (NYSE:JNJ), Bristol-Myers Squibb (NYSE:BMY), Pfizer (NYSE:PFE), Roche (NASDAQ:RHHBY) and Merck (NYSE:MRK) in pharmaceutical universe ... J&J appears to be a relatively safe dividend stock. Johnson & …
Trefis · 7/15/2015
Bristol Myers Squibb